ライフサイエンスコーパス: drug use disorder

1 not experiencing homelessness and having no drug use disorder).

2 rder to 33.3%(95%CI:18.7;48.0) for any other drug use disorder.

3 ith schizophrenia, alcohol use disorder, and drug use disorder.

4 use disorder and 85.1% of those with illicit drug use disorder.

5 der and 6.5% (95% CI, 5.7-7.3) had a current drug use disorder.

6 sonality and attitudes, and parental alcohol/drug use disorder.

7 and lower self-esteem, and parental alcohol/drug use disorder.

8 cohol use disorder and 38.9% (31.5-46.2) for drug use disorder.

9 during long-term follow-up, as did comorbid drug-use disorder.

10 associated HIV infections with treatment for drug use disorders.

11 or depression to 2.3 (95% CI [2.2; 2.4]) for drug use disorders.

12 uted to the increasing number of deaths from drug use disorders.

13 isk ranged from 16% for depression to 2% for drug use disorders.

14 with co-occurring PTSD and alcohol or other drug use disorders.

15 ropsychiatric conditions, and in alcohol and drug use disorders.

16 dysfunction is implicated in psychiatric and drug use disorders.

17 major depression, alcohol use disorders, and drug use disorders.

18 and should be further pursued in alcohol and drug use disorders.

19 o-occurring psychiatric disorders, including drug use disorders.

20 ed people who have comorbid mental and other drug use disorders.

21 cluding GABRA2, which has been implicated in drug use disorders.

22 lcohol use disorders, and 5.1% (2.9-7.8) for drug use disorders.

23 subjects with no prior clinical features of drug use disorders.

24 pite known risks for future opioid and other drug use disorders.

25 ween PTSD, exposure to traumatic events, and drug use disorders.

26 traditional instruments for both alcohol and drug use disorders.

27 eriencing homelessness (PEH) with alcohol or drug use disorders.

28 or depression to 3.0 (95% CI [2.9; 3.1]) for drug use disorders.

29 those experiencing homelessness and having a drug use disorder: 15.3 [14.1-16.7] in men and 40.1 [33.

30 cohol use disorders (1.7%, 1,406/82,731) and drug use disorders (2.1%, 1,216/57,901) had the highest

31 ved for those with previous homelessness and drug use disorder (25.0, 21.6-28.9) compared with those

32 %, 16-277), cirrhosis (65%, ?15 to 107), and drug use disorders (577%, 71-942) to premature mortality

33 % vs. 32.9%), alcohol (77.6% vs. 45.0%), and drug-use disorders (69.4% vs. 31.1%).

34 ed similar moderately weak associations with drug use disorders (8% minimum risk increase), migraine

35 2.57; 95% CI, 18.20-2.04) and with comorbid drug use disorders (aHR, 1.48; 95% CI, 1.17-1.88), but n

36 e of peer social genetic effects on risk for drug use disorder, alcohol use disorder (AUD), major dep

37 ty and stress related disorders, depression, drug use disorders, alcohol use disorders and bipolar an

38 ajor depressive disorder, anxiety disorders, drug use disorders, alcohol use disorders and self-harm.

39 Drug use disorders also were more highly associated with

40 for 82.9% of young adults with prescription drug use disorder and 85.1% of those with illicit drug u

41 s with AUD was greatest for AUD, followed by drug use disorder and attention deficit hyperactivity di

42 range, 1.01-1.59), with stronger effects for drug use disorder and AUD than for major depression and

43 to suffer from depression, alcoholism, and a drug use disorder and to suffer more psychiatric disorde

44 ffects on violent reoffending of alcohol and drug use disorders and bipolar disorder than of other ps

45 s, we found that 70q0 notably increased from drug use disorders and conflict and terrorism.

46 Drug use disorders and low back pain are projected to be

47 tions, commonly received services related to drug use disorders and mental disorders in the last year

48 Rates of drug use disorders and nicotine dependence were also ele

49 use, prescription drug misuse, prescription drug use disorder, and other drug use disorders based on

50 is C virus infection, alcohol use disorders, drug use disorders, and history of chronic obstructive p

51 ry of use of illicit drugs, history of other drug use disorders, and history of illegal behaviors.

52 ss disorder, anxiety, alcohol use disorders, drug use disorders, and self-harm); physical disorders (

53 Drug use disorders are an increasing cause of disability

54 that increased 70q0 for males also included drug use disorders, as well as diabetes.

55 ome baseline disorders predicted alcohol and drug use disorders at follow-up.

56 n rates, and age-standardised mortality from drug use disorders at the county level in the USA.

57 rders, at 36.7% (95% CI 27.7% to 46.2%), and drug use disorders, at 21.7% (95% CI 13.1% to 31.7%), fo

58 der, anxiety disorder, alcohol use disorder, drug use disorder, attention deficit hyperactivity disor

59 wedish medical and criminal registries: AUD, drug use disorders, attention deficit hyperactivity diso

60 has long-reaching consequences on risks for drug use disorder, AUD, major depression, and anxiety di

61 Outcomes were drug use disorder, AUD, major depression, and anxiety di

62 e, prescription drug use disorder, and other drug use disorders based on Diagnostic and Statistical M

63 d conditions (N=42,412) and those with other drug use disorders (cannabis, cocaine, alcohol, and opio

64 sibility of shared vulnerability to PTSD and drug use disorders cannot be ruled out.

65 iagnosis of tobacco or alcohol use disorder, drug use disorder, chronic pain diagnosis, mental health

66 d YLL rates increased for Alzheimer disease, drug use disorders, chronic kidney disease, kidney cance

67 nt of female and 38% of male offenders had a drug-use disorder, compared with 16% and 21%, respective

68 osis were predictive of any adverse outcome: drug use disorders, criminality, and self-harm, which we

69 e number of SUDs at baseline, remission from drug use disorders decreased the odds of a new-onset SUD

70 viduals in the general population with DSM-5 drug use disorder (DUD) is limited.

71 tic heterogeneity for five primary disorders-Drug Use Disorder (DUD), Alcohol Use Disorder (AUD), Maj

72 UD, including alcohol use disorder (AUD) and drug use disorder (DUD), and the risk of mortality were

73 sorders: major depression (MD, N = 158,557), drug use disorder (DUD, N = 69,841), bipolar disorder (B

74 accurate diagnosis of unhealthy drug use or drug use disorders, effective treatment, and appropriate

75 xiety, personality disorder, and alcohol and drug use disorders), engage in suicidal behaviours, and

76 mong the offspring more strongly for AUD and drug use disorder, followed by attention deficit hyperac

77 re estimated for alcohol use disorder (AUD), drug use disorders, functional impairment, liver disease

78 (95% CI, 43.9-51.6) of those with a current drug use disorder had at least 1 PD.

79 Most individuals with drug use disorders have never been treated, and treatmen

80 est for AUD (hazard ratio=2.36), followed by drug use disorder (hazard ratio=2.04), attention deficit

81 bsessive-compulsive disorder interacted with drug use disorders in black men.

82 omparison, there was an increase in 70q0 for drug use disorders in the high-income super-region, whic

83 epidemiology of DSM-IV 12-month and lifetime drug use disorders in the United States has not been ava

84 personality disorders (PDs) and alcohol and drug use disorders in the US population.

85 An exception was that remission from a drug use disorder increased the odds of a new SUD (odds

86 for nicotine dependence or alcohol or other drug use disorders, independent of posttraumatic stress

87 -occurring psychiatric disorders, especially drug use disorders (IRR in those experiencing homelessne

88 The co-occurrence of PDs with alcohol and drug use disorders is pervasive in the US population.

89 The age-standardised DALY rate due to drug use disorders is projected to increase considerably

90 een posttraumatic stress disorder (PTSD) and drug use disorders, little is known about causal relatio

91 nts or adults who have a currently diagnosed drug use disorder or are currently undergoing or have be

92 djusted and adjusted) to have a diagnosis of drug use disorder or nicotine dependence or to have used

93 ght be a causal risk factor for nicotine and drug use disorders or, alternatively, the co-occurrence

94 Further, tuberculosis (OR 1.3-2.1-3.2), drug use disorder (OR 1.1), hepatitis (OR 13.1), HIV/AID

95 sorder: OR, 9.5; 95% CI, 6.4-14.1; any other drug use disorder: OR, 2.6; 95% CI, 1.6-4.4; and nicotin

96 proportion of persons seeking treatment for drug use disorders owing to the high global prevalence o

97 stress disorder (P=.008), and diagnosis of a drug use disorder (P= .03) significantly shortened the e

98 ss disorder might be a causal determinant of drug use disorders, possibly representing complications

99 6 times higher, major depression and illicit drug use disorder prevalence were both six times higher,

100 of within-county variation in mortality from drug use disorders (R(2)=0.975).

101 Healthy adults (N = 29) with no history of drug use disorder received combinations of placebo, hydr

102 Association of PTSD with subsequent incident drug use disorders remained substantial after statistica

103 RR, 1.57 [95% CI, 1.19-2.04), diagnosis of a drug use disorder (RR, 1.29 [95% CI, 1.01-1.65]), and po

104 imary Care Evaluation of Mental Disorders, a drug use disorders screen, the Sheehan Disability Scale,

105 Individuals with drug use disorders seek drugs over other rewarding activ

106 ersonality disorders, alcohol use disorders, drug use disorders, suicidal behaviours, and premature m

107 ld for baseline alcohol, cannabis, and other drug use disorder symptoms.

108 o receive past-year treatment for alcohol or drug use disorders than their non-college-attending peer

109 and history of other psychiatric or illicit drug use disorder, the estimated relative risk for heavy

110 ic brain injury (TBI), alcohol use disorder, drug use disorder, tobacco use disorder, and hearing los

111 luded pharmacotherapies for alcohol or other drug use disorders, trauma-focused integrated therapies,

112 he care of patients with DUA-IE and included drug use disorder treatment, decisions about surgery, an

113 Drug use disorder was generally greater among men, white

114 escription anxiety medication and associated drug use disorders was computed for individuals who had

115 ciations between PTSD, traumatic events, and drug use disorders were analyzed by using Cox proportion

116 han in the eastern Mediterranean region; and drug use disorders were more prevalent in the eastern Me

117 Associations between PDs and alcohol and drug use disorders were overwhelmingly positive and sign

118 Alcohol and drug use disorders were present in 17% and 19%, respecti

119 , alcohol use disorder, eating disorders and drug use disorders were rated as moderately weak, reflec

120 and antisocial PDs and specific alcohol and drug use disorders were significantly stronger (P <.04)

121 ntified as HHV-8-positive, with a history of drug use disorder, were transplanted into 22 recipients.

122 Comorbidity of drug use disorders with other substance use disorders an

123 Associations of drug use disorders with other substance use disorders an

124 ith schizophrenia, alcohol use disorder, and drug use disorder (with and without homelessness history

125 risk of schizophrenia than those with other drug use disorders, with the exception of cannabis use d

126 ld income, incarceration, and mortality from drug use disorders within counties over time.